7RD3
Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m42.126
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-ID |
Synchrotron site | APS |
Beamline | 22-ID |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-04-16 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 1 |
Spacegroup name | P 1 |
Unit cell lengths | 54.854, 57.176, 74.493 |
Unit cell angles | 86.50, 76.86, 72.44 |
Refinement procedure
Resolution | 44.380 - 1.810 |
R-factor | 0.2183 |
Rwork | 0.216 |
R-free | 0.26000 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6b5l |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX (1.19.1_4122) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 1.840 |
High resolution limit [Å] | 1.810 | 4.910 | 1.810 |
Rmerge | 0.068 | 0.038 | 0.430 |
Rmeas | 0.082 | 0.046 | 0.518 |
Rpim | 0.046 | 0.025 | 0.285 |
Total number of observations | 198861 | ||
Number of reflections | 66229 | 3061 | 3262 |
<I/σ(I)> | 7.5 | ||
Completeness [%] | 86.3 | 79.6 | 84.8 |
Redundancy | 3 | 2.8 | 2.9 |
CC(1/2) | 0.997 | 0.876 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.1 M sodium citrate tribasic dihydrate, pH 5.5, 18% w/v PEG3350 |